西格玛-1受体:抗抑郁药的一种机械学信息的治疗点
Naomi Xiao1,2, Liyang Yin1, Kayla M Teopiz1
1Department of Research, Brain and Cognition Discovery Foundation, Toronto, Canada.
Expert opinion on therapeutic targets
|April 29, 2025
概括
西格玛-1受体 (S1Rs) 是抗抑郁药活性的关键媒介,影响神经递质释放和细胞内. 对于开发重大抑郁症和其他心理健康状况的新疗法,S1R调制至关重要.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗抑郁药作用的确切机制仍然不完全理解.
- 慢性压力影响神经发生,神经差异化和神经可塑性,涉及超出单胺的各种分子效应因子.
- 西格玛-1受体 (S1Rs) 正在成为中介抗抑郁药效应的重要点.
研究的目的:
- 综合关于S1Rs在抗抑郁机制中的作用的证据.
- 探索S1Rs.的生理和病理生理功能.
- 评估S1R调节对当前和未来抗抑郁药疗法的相关性.
主要方法:
- 系统审查和综合到2024年8月的临床前和临床试验数据.
- 对S1R参与神经递质调节,细胞内信号传递和免疫反应的分析.
- 对FDA批准的抗抑郁药标签对S1R活性进行检查.
主要成果:
- S1Rs调节神经递质的可用性和释放,包括单胺和谷氨酸.
- S1R活动影响细胞内 (Ca2+) 稳态,并调节免疫-炎症通路.
- 美国食品和药物管理局 (FDA) 承认S1R参与了德克斯特罗米多芬-布普罗的机制,这标志着抗抑郁药研究的重大转变.
结论:
- 西格玛-1受体调节是FDA批准的抗抑郁药的作用机制不可或缺的组成部分,例如德克斯特罗米多芬-布普罗.
- 针对sigma-1系统为发现和开发用于抑郁和其他精神障碍的新疗法提供了一个有希望的途径.
- 需要进一步的研究来确定西格玛-1调制是否可以专门解决具有挑战性的精神病理维度,例如无情感.
关键词:
西格玛-1受体是一个受体.这是一个无情的世界,无情的世界.抗抑郁药是一种抗抑郁药.认知 认知 认知德克斯特罗梅多尔 (Dextromethorphan) 是一种可怕的药物.谷氨酸酸盐的使用方法胺基氨酸 (ketamine) 是一种可靠的药物.更多相关视频
12:27A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
3.3K
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
1.1K
相关概念视频
G-protein Coupled Receptors
112.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
112.1K
G Protein-coupled Receptors
10.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
10.6K
Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
227
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
227
Adrenergic Receptors: ɑ Subtype
1.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.3K
